Ottawa, Canada

Daniel J McKay

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Chute a Blondeau, CA (2011 - 2014)
  • Ottawa, CA (2002 - 2015)

Company Filing History:


Years Active: 2002-2015

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: The Innovations of Daniel J McKay

Introduction

Daniel J McKay is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as HIV protease inhibitors and renin inhibitors. With a total of 6 patents to his name, McKay's work has had a profound impact on medical science.

Latest Patents

One of McKay's latest patents involves sulfonamides as HIV protease inhibitors. This patent discloses compounds of Formula I, which include compounds that can be metabolized in vivo to HIV protease inhibitors. These compounds and their pharmaceutically acceptable salts are useful for the prophylaxis or treatment of HIV infection and the delay in the onset of AIDS. Another significant patent focuses on 3,4-substituted piperidine derivatives as renin inhibitors. This invention relates to compounds that bear oxopyridine at the 4-position and are used in treating cardiovascular events and renal insufficiency.

Career Highlights

Throughout his career, McKay has worked with prominent companies such as Merck Canada Inc. and Merck Frosst Canada & Co. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Some of McKay's notable coworkers include Christopher I Bayly and Erich L Grimm. Their collaborative efforts have contributed to the advancement of research and development in their respective fields.

Conclusion

Daniel J McKay's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare. His work continues to influence the development of treatments for serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…